These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 18097037)

  • 1. Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice.
    DiLillo DJ; Hamaguchi Y; Ueda Y; Yang K; Uchida J; Haas KM; Kelsoe G; Tedder TF
    J Immunol; 2008 Jan; 180(1):361-71. PubMed ID: 18097037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody.
    Alwayn IP; Xu Y; Basker M; Wu C; Buhler L; Lambrigts D; Treter S; Harper D; Kitamura H; Vitetta ES; Abraham S; Awwad M; White-Scharf ME; Sachs DH; Thall A; Cooper DK
    Xenotransplantation; 2001 Aug; 8(3):157-71. PubMed ID: 11472623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of the plasma cell pool is independent of memory B cells.
    Ahuja A; Anderson SM; Khalil A; Shlomchik MJ
    Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4802-7. PubMed ID: 18339801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exploratory investigation of the effect of arsenic trioxide on anti-Gal antibody production in baboons.
    Gollackner B; Ryan D; Knosalla C; Basker M; Alwayn IP; Harper D; Salomon G; Mauiyyedi S; Correa L; Thall A; Cooper DK
    Xenotransplantation; 2003 Jan; 10(1):80-7. PubMed ID: 12535229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice.
    Hamaguchi Y; Uchida J; Cain DW; Venturi GM; Poe JC; Haas KM; Tedder TF
    J Immunol; 2005 Apr; 174(7):4389-99. PubMed ID: 15778404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice.
    Khodadadi L; Cheng Q; Alexander T; Sercan-Alp Ö; Klotsche J; Radbruch A; Hiepe F; Hoyer BF; Taddeo A
    PLoS One; 2015; 10(8):e0135081. PubMed ID: 26252021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.
    Hamaguchi Y; Xiu Y; Komura K; Nimmerjahn F; Tedder TF
    J Exp Med; 2006 Mar; 203(3):743-53. PubMed ID: 16520392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions.
    Xiu Y; Wong CP; Bouaziz JD; Hamaguchi Y; Wang Y; Pop SM; Tisch RM; Tedder TF
    J Immunol; 2008 Mar; 180(5):2863-75. PubMed ID: 18292508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy.
    Bhoj VG; Arhontoulis D; Wertheim G; Capobianchi J; Callahan CA; Ellebrecht CT; Obstfeld AE; Lacey SF; Melenhorst JJ; Nazimuddin F; Hwang WT; Maude SL; Wasik MA; Bagg A; Schuster S; Feldman MD; Porter DL; Grupp SA; June CH; Milone MC
    Blood; 2016 Jul; 128(3):360-70. PubMed ID: 27166358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B lymphocytes differentially influence acute and chronic allograft rejection in mice.
    DiLillo DJ; Griffiths R; Seshan SV; Magro CM; Ruiz P; Coffman TM; Tedder TF
    J Immunol; 2011 Feb; 186(4):2643-54. PubMed ID: 21248259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome.
    Rizzi M; Knoth R; Hampe CS; Lorenz P; Gougeon ML; Lemercier B; Venhoff N; Ferrera F; Salzer U; Thiesen HJ; Peter HH; Walker UA; Eibel H
    PLoS One; 2010 May; 5(5):e10838. PubMed ID: 20520773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hapten-induced primary and memory humoral responses are inhibited by the infusion of anti-CD20 monoclonal antibody (IDEC-C2B8, Rituximab).
    Gonzalez-Stawinski GV; Yu PB; Love SD; Parker W; Davis RD
    Clin Immunol; 2001 Feb; 98(2):175-9. PubMed ID: 11161973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
    Chen D; Ireland SJ; Davis LS; Kong X; Stowe AM; Wang Y; White WI; Herbst R; Monson NL
    J Immunol; 2016 Feb; 196(4):1541-9. PubMed ID: 26764035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV.
    Minard-Colin V; Xiu Y; Poe JC; Horikawa M; Magro CM; Hamaguchi Y; Haas KM; Tedder TF
    Blood; 2008 Aug; 112(4):1205-13. PubMed ID: 18495955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice.
    Haas KM; Watanabe R; Matsushita T; Nakashima H; Ishiura N; Okochi H; Fujimoto M; Tedder TF
    J Immunol; 2010 May; 184(9):4789-800. PubMed ID: 20368280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergy for a lifetime?
    Luger EO; Wegmann M; Achatz G; Worm M; Renz H; Radbruch A
    Allergol Int; 2010 Mar; 59(1):1-8. PubMed ID: 20186004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term maintenance of polysaccharide-specific antibodies by IgM-secreting cells.
    Foote JB; Mahmoud TI; Vale AM; Kearney JF
    J Immunol; 2012 Jan; 188(1):57-67. PubMed ID: 22116821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of Virus-Specific Antibody after Depletion of Memory B Cells.
    Langley WA; Wieland A; Ahmed H; Rasheed MAU; Davis CW; Sewatanon J; Mueller SN; Shlomchik MJ; Zarnitsyna VI; Antia R; Ahmed R
    J Virol; 2022 May; 96(9):e0002622. PubMed ID: 35404084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade.
    Lin WY; Gong Q; Seshasayee D; Lin Z; Ou Q; Ye S; Suto E; Shu J; Lee WP; Lee CW; Fuh G; Leabman M; Iyer S; Howell K; Gelzleichter T; Beyer J; Danilenko D; Yeh S; DeForge LE; Ebens A; Thompson JS; Ambrose C; Balazs M; Starovasnik MA; Martin F
    Blood; 2007 Dec; 110(12):3959-67. PubMed ID: 17687108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting.
    Baert L; Manfroi B; Casez O; Sturm N; Huard B
    J Autoimmun; 2018 Dec; 95():179-190. PubMed ID: 30385081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.